Neolpharma, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 99 Jardines Street, Caguas, Puerto Rico (PR) 00725, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3009993897 · DUNS 078709787
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-03-10
- VAIDrug Quality Assurance2022-04-01
- VAIDrug Quality Assurance2019-02-05
- VAIDrug Quality Assurance2017-06-07
- VAIDrug Quality Assurance2015-06-18
- VAIDrug Quality Assurance2013-03-07
Drugs this plant is listed as making
6 distinct drugs across 30 products name this site in their FDA label.
- atorvastatin calciumBiocon Pharma Inc.
- Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine SulfateGlenmark Pharmaceuticals Inc., Usa
- Levothyroxine SodiumLannett Company, Inc
- linezolidPharmacia & Upjohn Company LLC
- Oseltamivir PhosphateExelan Pharmaceuticals, Inc.
- theophylline anhydrousENDO USA, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.